DMII (Drugs Made In America Acquisition II) Shares Buyback Ratio %: 0.00 (As of Jul. 11, 2026)


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II Shares Buyback Ratio %?

Drugs Made In America Acquisition II DMII 15 Shares Buyback Ratio % is 0.00 as of Jul. 11, 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Drugs Made In America Acquisition II's current shares buyback ratio was 0.00%.

Drugs Made In America Acquisition II Shares Buyback Ratio % Related Terms

Drugs Made In America Acquisition II Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Drugs Made In America Acquisition II's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition II Shares Buyback Ratio % Chart

Drugs Made In America Acquisition II Annual Data
Trend Dec24 Dec25
Shares Buyback Ratio %
0.00 0.00

Drugs Made In America Acquisition II Quarterly Data
Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Buyback Ratio % Get a 7-Day Free Trial 0.00 0.00 -2.94 2.86 0.00
DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II Shares Buyback Ratio % Calculation

Drugs Made In America Acquisition II's Shares Buyback Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(0 - 63.700) / 0
=N/A%

Drugs Made In America Acquisition II's Shares Buyback Ratio for the quarter that ended in Mar. 2026 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2025 ) - Shares Outstanding (EOP) (A: Mar. 2026 )) / Shares Outstanding (EOP) (A: Dec. 2025 )
=(63.700 - 63.700) / 63.700
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of 0.00 mean?
Drugs Made In America Acquisition II (DMII) has a Shares Buyback Ratio % of 0.00 as of Jul. 11, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Drugs Made In America Acquisition II and its competitors.
Is Drugs Made In America Acquisition II's Shares Buyback Ratio % too high?
Drugs Made In America Acquisition II's current Shares Buyback Ratio % is 0.00. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's Shares Buyback Ratio % compare to BCSS and EVAC?
Drugs Made In America Acquisition II's Shares Buyback Ratio % of 0.00 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Diversified Financial Services company?
A good Shares Buyback Ratio % depends on the Diversified Financial Services industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current Shares Buyback Ratio % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current Shares Buyback Ratio % of 0.00. The current Shares Buyback Ratio % is 0.00. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current Shares Buyback Ratio % is 0.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price